The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
29 09 2022
Historique:
received: 10 11 2021
pubmed: 21 2 2022
medline: 4 10 2022
entrez: 20 2 2022
Statut: ppublish

Résumé

Syringes with attached needles (termed fixed low dead space syringes [LDSS]) retain less blood following injection than syringes with detachable needles, but evidence on them reducing blood-borne virus transmission among people who inject drugs (PWID) is lacking. Utilizing the UK Unlinked Anonymous Monitoring cross-sectional bio-behavioral surveys among PWID for 2016/18/19 (n = 1429), we showed that always using fixed LDSS was associated with 76% lower likelihood (adjusted odds ratio  = 0.24, 95% confidence interval [CI]: .08-.67) of recent hepatitis C virus infection (RNA-positive and antibody-negative) among antibody-negative PWID compared to using any syringes with detachable needles.

Identifiants

pubmed: 35184173
pii: 6532589
doi: 10.1093/cid/ciac140
pmc: PMC9522423
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073-1077

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N00616X/1
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R21 DA047902
Pays : United States
Organisme : Wellcome Trust
ID : 222770/Z/21/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. P. V. reports unrestricted research funding off Gilead unrelated to this work. M. H. reports personal fees from Gilead, Abbvie, and MSD as unrestricted speaker fees and support for travel in last 5 years and is Trustee of Society of Study of Addiction and Regional Editor of Addiction. C. T. reports funding awarded to the institution from the National Institute for Health Research Health Protection Research Unit in Behavioral Science and Evaluation and National Institute for Health Research Applied Collaboration West outside of the submitted work. 
P. V. reports grant made to institution from National Institute for Health Research Health Protection Research Unit in Behavioral Science and Evaluation outside of the submitted work. J. K. reports being partly funding by NIHR ARC West and NIHR HPRU in BSE via the University of Bristol for the current study. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Références

Lancet Public Health. 2021 May;6(5):e309-e323
pubmed: 33780656
Drug Alcohol Depend. 2009 Mar 1;100(3):204-13
pubmed: 19004579
Addiction. 2020 Apr;115(4):702-713
pubmed: 31633849
Drug Alcohol Depend. 2018 Nov 1;192:118-124
pubmed: 30245460
J Clin Microbiol. 2008 Feb;46(2):499-506
pubmed: 18032621
Cochrane Database Syst Rev. 2017 Sep 18;9:CD012021
pubmed: 28922449
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
Int J Drug Policy. 2014 May;25(3):363-71
pubmed: 24561223
Int J Drug Policy. 2017 Jan;39:99-108
pubmed: 27788406
Curr Opin HIV AIDS. 2012 Jul;7(4):369-75
pubmed: 22627710
Lancet Infect Dis. 2018 Dec;18(12):1397-1409
pubmed: 30385157
Euro Surveill. 2018 Nov;23(47):
pubmed: 30482265
Harm Reduct J. 2018 Jan 15;15(1):3
pubmed: 29334973
Clin Infect Dis. 2017 Apr 01;64(7):860-869
pubmed: 28362947
Harm Reduct J. 2015 Oct 16;12:37
pubmed: 26472669
J Infect Dis. 2010 Oct 1;202(7):984-90
pubmed: 20726768
PLoS One. 2015 Nov 04;10(11):e0139737
pubmed: 26536599
Soc Sci Med. 2002 Oct;55(7):1103-13
pubmed: 12365524
Lancet Glob Health. 2017 Dec;5(12):e1208-e1220
pubmed: 29074410

Auteurs

Adam Trickey (A)

Population Health Sciences, University of Bristol, Bristol, United Kingdom.

Sara Croxford (S)

UK Health Security Agency, London, United Kingdom.

Eva Emanuel (E)

UK Health Security Agency, London, United Kingdom.

Samreen Ijaz (S)

UK Health Security Agency, London, United Kingdom.

Matthew Hickman (M)

Population Health Sciences, University of Bristol, Bristol, United Kingdom.
NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, United Kingdom.

Joanna Kesten (J)

Population Health Sciences, University of Bristol, Bristol, United Kingdom.
NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, United Kingdom.
The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, United Kingdom.

Clare Thomas (C)

Population Health Sciences, University of Bristol, Bristol, United Kingdom.
NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, United Kingdom.
The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, United Kingdom.

Claire Edmundson (C)

UK Health Security Agency, London, United Kingdom.

Monica Desai (M)

UK Health Security Agency, London, United Kingdom.

Peter Vickerman (P)

Population Health Sciences, University of Bristol, Bristol, United Kingdom.
NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH